I believe patients deserve a surgeon who listens to them. It's important to hear their concerns. This feedback is an important part of determining a care plan, including an operation that fits their expectations. My desire is to offer patients the least "invasive" operation that meets their needs.
The best part of working at The Ohio State University Wexner Medical Center is the people. There is a noticeable commitment to offering the highest quality of care. I love being surrounded by really smart individuals who are passionate about what they do.
In my free time I enjoy reading, relaxing with my family and spending time outdoors. I am an avid tennis player and also enjoy shooting trap and sporting clays.
- Director, Center for Minimally Invasive Surgery
- Medical Director, Metabolic and Bariatric Surgery and Comprehensive Weight Management Program
- Founding President, Ohio Society for Bariatric Surgery
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2015, 2016
Mount Sinai School of Medicine SUNY
Specialties and conditions I treat
- General Surgery
- Bariatric Surgery
- Gastric Bypass
- Obesity, Morbid
- Digestive System Diseases
- Minimally Invasive Surgical Procedures
- Digestive System Surgical Procedures
- Hernia, Hiatal
- Hernia, Ventral
- General Surgery
Locations where I practice
More about my work
American Board of Surgery
General and Gastrointestinal Surgery
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Needleman has reported no financial relationships with medical device, research and/or drug companies.